Beijing Novotel Biotechnology Co., Ltd.

Using the original drug PLIAGLIS ® as a positive control, a randomized, double-blind, self-controlled clinical trial was conducted to verify the effectiveness of the experimental drug lidocaine tetracaine cream for local anesthesia of intact skin before superficial skin surgery in adults. The safety of lidocaine tetracaine cream was verified through laboratory tests, clinical symptoms, signs, adverse events, etc.

Main research purpose: This study uses liraglutide injection (3ml: 18mg) produced by Beijing Nobot Biotechnology Co., Ltd. as the test preparation (T), and liraglutide injection (3ml: 18mg, trade name: Novo®) produced by the original manufacturer Novo Nordisk of Denmark as the reference preparation (R) to evaluate the pharmacokinetic similarity of the test preparation (T) and the reference preparation (R). Secondary research purpose: To observe the safety and immunogenicity of the test preparation (T) and the reference preparation (R) in healthy subjects.